`ESTTA1233380
`09/02/2022
`
`ESTTA Tracking number:
`
`Filing date:
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Applicants
`
`Application serial no.
`
`Application filing date
`
`Mark
`
`Date of publication
`
`Potential opposer's
`Correspondence information
`
`Covidien LP
`
`97431663
`
`05/27/2022
`
`MULTIFIRE ENDO HERNIA
`
`08/23/2022
`
`CAMILLE M. MILLER
`COZEN O'CONNOR
`1650 MARKET STREET
`SUITE 2800
`PHILADELPHIA, PA 19103
`UNITED STATES
`Primary email: cmiller@cozen.com
`Secondary email(s): czucker@cozen.com,
`lcosta@cozen.com, phipdocketing@cozen.com
`2156657273
`
`Docket no.
`
`x/364672
`
`First 30 Day Request for Extension of Time to Oppose
`
`Pursuant to 37 C.F.R. Section 2.102, Endo Pharmaceuticals Inc., 1400 Atwater Drive, Malvern, PA 19355,
`UNITED STATES, a corporation organized under the laws of Delaware, respectfully requests that it be gran-
`ted a 30-day extension of time to file a notice of opposition against the above-identified mark.
`The time within which to file a notice of opposition is set to expire on 09/22/2022. Endo Pharmaceuticals Inc.
`respectfully requests that the time period within which to file an opposition be extended until 10/22/2022.
`Respectfully submitted,
`/Camille M. Miller/
`Camille M. Miller
`cmiller@cozen.com
`09/02/2022
`
`



